Shilpa Medicare announced favorable topline Phase 3 results of its new drug OERIS (Ondansetron Extended Release Injection). OERIS is a weekly medication that is used to prevent chemotherapy-induced nausea and vomiting (CINV). The multicentric...
.png "Lupin Expands Vizag Facility with New Oncology Manufacturing Unit")
Lupin Manufacturing Solutions (LMS), a fully owned subsidiary of a multinational pharmaceutical company Lupin, has also established a separate Oncology Block in its Vizag plant in India. This high-capacity unit will increase the end-to-end CDMO...
The Pan American Health Organization (PAHO) has placed a $4.75 million (Rs 41 crore) order with Panacea Biotec to supply the Easyfive TT vaccine under a long-term contract
BASF and Beyond Suncare express their approval of the World Health Organization's (WHO) decision to incorporate broad-spectrum sunscreen with a high SPF into the 24th edition of the Model List of Essential Medicines (EML) and the 10th edition of the
.jpg "Novo Nordisk Lowers Wegovy Cost to Boost India Market")
Danish pharmaceutical company Novo Nordisk (NOVOb.CO), opens new tab announced on Tuesday that it has reduced the price of its weight-loss medication, Wegovy, by as much as 37% from its initial launch price in India, as it aims to strengthen
AstraZeneca’s Baxdrostat has achieved a major milestone in the treatment of resistant hypertension (rHTN).Phase III trials demonstrate very large and long-term improvements in blood-pressure. The drug blocks the hormone aldosterone by inhibiting...
.png "Zydus Secures NMPA Clearance for Venlafaxine Generic")
Zydus Lifesciences has been granted consent by the National Medical Products Administration (NMPA) of China on its generic form of Venlafaxine Extended-Release capsules that is applied in the treatment of depressive and anxiety disorders...
Indian pharma companies Cipla, Natco Pharma, Hetero Labs, and Annora Pharma have achieved a breakthrough in China after securing key bids to supply generic drugs under the country’s latest volume-based procurement (VBP) program...
Teva Pharmaceuticals, a U.S. subsidiary of Teva Pharmaceutical Industries Ltd., has announced new findings from the ongoing real-world IMPACT-TD Registry, which underscore the beneficial effects of AUSTEDO (deutetrabenazine) tablets and AUSTEDO XR
Ascelia Pharma AB (publ), a biotech focused on improving the life of people living with rare cancer conditions, announced the filing of a new patent application for its first-in-class orphan liver imaging drug Orviglance
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")